These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15659730)

  • 1. Reducing the risks of gastrointestinal bleeding with antiplatelet therapies.
    Cryer B
    N Engl J Med; 2005 Jan; 352(3):287-9. PubMed ID: 15659730
    [No Abstract]   [Full Text] [Related]  

  • 2. [ASS or clopidogrel plus esomeprazole after bleeding from an ulcer].
    Nitschmann S; Mössner J
    Internist (Berl); 2005 Dec; 46(12):1405-8. PubMed ID: 16220275
    [No Abstract]   [Full Text] [Related]  

  • 3. Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding.
    Wolk MJ; Jacobs AK
    N Engl J Med; 2005 Apr; 352(16):1716-8; author reply 1716-8. PubMed ID: 15843675
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dilemma between gastroprotection and cardiovascular prevention].
    Venerito M; Kandulski A; Malfertheiner P
    Dtsch Med Wochenschr; 2010 Nov; 135(44):2193-8. PubMed ID: 20979006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding.
    Wargo KA; Baty SR; Knowles G
    N Engl J Med; 2005 Apr; 352(16):1716-8; author reply 1716-8. PubMed ID: 15846858
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
    Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
    Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
    [No Abstract]   [Full Text] [Related]  

  • 7. Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding.
    Barski PR
    N Engl J Med; 2005 Apr; 352(16):1716-8; author reply 1716-8. PubMed ID: 15846857
    [No Abstract]   [Full Text] [Related]  

  • 8. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.
    Chan FK; Ching JY; Hung LC; Wong VW; Leung VK; Kung NN; Hui AJ; Wu JC; Leung WK; Lee VW; Lee KK; Lee YT; Lau JY; To KF; Chan HL; Chung SC; Sung JJ
    N Engl J Med; 2005 Jan; 352(3):238-44. PubMed ID: 15659723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HP eradication prevents recurrent hemorrhages caused by acetylsalicylic acid].
    Labenz J
    MMW Fortschr Med; 2013 Jun; 155(12):31. PubMed ID: 23923307
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of GI bleeding due to antiplatelet agents: a labyrinth!].
    Bretagne JF
    Presse Med; 2009 Dec; 38(12):1722-6. PubMed ID: 19914029
    [No Abstract]   [Full Text] [Related]  

  • 11. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
    Hsu PI
    J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
    Morini S; Zullo A
    G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gastric protection and treatment with low-dose aspirin].
    Agustí-Escasany A; Vallano-Ferraz A
    Med Clin (Barc); 2006 Feb; 126(6):232-3. PubMed ID: 16510098
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiplatelet agents and proton pump inhibitors. How can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?].
    Casado-Arroyo R; Muñoz-Villalenguas M; Lanas Arbeloa A
    Gastroenterol Hepatol; 2011; 34(7):478-91. PubMed ID: 21684042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of patients with high gastrointestinal risk on antiplatelet therapy.
    Cryer B
    Gastroenterol Clin North Am; 2009 Jun; 38(2):289-303. PubMed ID: 19446259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Might proton pump inhibitors prevent the antiplatelet effects of low- or very low-dose aspirin?
    Fernández-Fernández FJ
    Arch Intern Med; 2002 Oct; 162(19):2248. PubMed ID: 12390073
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiplatelet therapy after aspirin-induced upper gastrointestinal bleeding].
    Johansen M
    Tidsskr Nor Laegeforen; 2006 Nov; 126(21):2802-4. PubMed ID: 17086221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal drug therapy after aspirin-induced upper gastrointestinal bleeding.
    Struijk M; Postma DF; van Tuyl SA; van de Ree MA
    Eur J Intern Med; 2012 Apr; 23(3):227-30. PubMed ID: 22385878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gastroenterology in family practice. Updates for your "stomach patient"].
    Stiefelhagen P
    MMW Fortschr Med; 2006 Jun; 148(22):4-6. PubMed ID: 16821566
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer.
    Luo JC; Huang KW; Leu HB; Chen LC; Hou MC; Li CP; Lu CL; Lin HC; Lee FY; Lee SD
    Aliment Pharmacol Ther; 2011 Sep; 34(5):519-25. PubMed ID: 21726257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.